相似文献
1
Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara.
J Nat Prod. 2008 Jun;71(6):1082-4. doi: 10.1021/np800098f. Epub 2008 May 8.
2
Radical scavenging and antioxidant activities of isocoumarins and a phthalide from the endophytic fungus Colletotrichum sp.
J Nat Prod. 2011 Jan 28;74(1):79-81. doi: 10.1021/np1003752. Epub 2010 Dec 21.
3
Dihydroisocoumarin from Xyris pterygoblephara active against dermatophyte fungi.
Phytochemistry. 2008 Jan;69(2):439-44. doi: 10.1016/j.phytochem.2007.08.002. Epub 2007 Sep 17.
4
Cytochrome P450 3A4 inhibitory constituents of the wood of Taxus yunnanensis.
J Nat Prod. 2011 Jan 28;74(1):102-5. doi: 10.1021/np100665j. Epub 2010 Dec 7.
5
Cytotoxic and Anti-Inflammatory Activities of Dihydroisocoumarin and Xanthone Derivatives from .
Molecules. 2021 Nov 1;26(21):6626. doi: 10.3390/molecules26216626.
6
Anti-tumor effect of Shu-Gan-Liang-Xue decoction in breast cancer is related to the inhibition of aromatase and steroid sulfatase expression.
J Ethnopharmacol. 2014 Jul 3;154(3):687-95. doi: 10.1016/j.jep.2014.04.045. Epub 2014 May 6.
7
Antiproliferative metabolites from the Northern African endemic plant Daucus virgatus (Apiaceae).
Phytochemistry. 2017 Nov;143:194-198. doi: 10.1016/j.phytochem.2017.08.010. Epub 2017 Aug 23.
8
Evaluation of Brazilian plants on cancer chemoprevention targets in vitro.
Phytother Res. 2010 Jun;24(6):928-33. doi: 10.1002/ptr.3050.
9
Synthesis, antiproliferative activities, and computational evaluation of novel isocoumarin and 3,4-dihydroisocoumarin derivatives.
Eur J Med Chem. 2016 Mar 23;111:103-13. doi: 10.1016/j.ejmech.2016.01.051. Epub 2016 Jan 30.
10
HPLC-based activity profiling for GABA(A) receptor modulators: a new dihydroisocoumarin from Haloxylon scoparium.
J Nat Prod. 2010 Apr 23;73(4):768-70. doi: 10.1021/np900803w.
引用本文的文献
1
()-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer.
Pharmaceuticals (Basel). 2025 Jan 17;18(1):118. doi: 10.3390/ph18010118.
2
Dinuclear Zn-Catalytic System as Brønsted Base and Lewis Acid for Enantioselectivity in Same Chiral Environment.
ACS Omega. 2024 Feb 5;9(6):6074-6092. doi: 10.1021/acsomega.3c07446. eCollection 2024 Feb 13.
3
Dihydroisocoumarins, Naphthalenes, and Further Polyketides from and : Isolation, Identification and Their 5-LOX/COX-1 Inhibiting Potency.
Molecules. 2021 Jul 12;26(14):4223. doi: 10.3390/molecules26144223.
4
Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1-1,2,4-triazoles and 1-(Diarylmethyl)-1-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer.
Pharmaceuticals (Basel). 2021 Feb 22;14(2):169. doi: 10.3390/ph14020169.
5
Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5.
Front Pharmacol. 2019 Apr 16;10:400. doi: 10.3389/fphar.2019.00400. eCollection 2019.
6
Uncovering the Mechanisms of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation by Focused Network Pharmacology Approach.
Front Pharmacol. 2018 Mar 26;9:270. doi: 10.3389/fphar.2018.00270. eCollection 2018.
7
Synthesis of isocoumarins with different substituted patterns via Passerini-aldol sequence.
Org Lett. 2014 Sep 5;16(17):4504-7. doi: 10.1021/ol502048e. Epub 2014 Aug 20.
8
Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.
Bioorg Med Chem. 2012 Apr 15;20(8):2603-13. doi: 10.1016/j.bmc.2012.02.042. Epub 2012 Feb 27.
9
Screening for compounds with aromatase inhibiting activities from Atractylodes macrocephala Koidz.
Molecules. 2011 Apr 14;16(4):3146-51. doi: 10.3390/molecules16043146.
10
Natural compounds with aromatase inhibitory activity: an update.
Planta Med. 2010 Aug;76(11):1087-93. doi: 10.1055/s-0030-1250169. Epub 2010 Jul 15.
本文引用的文献
1
Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/pi interaction.
Bioorg Med Chem. 2008 Jan 15;16(2):650-7. doi: 10.1016/j.bmc.2007.10.045. Epub 2007 Oct 22.
2
Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer.
Expert Rev Anticancer Ther. 2007 Sep;7(9):1243-53. doi: 10.1586/14737140.7.9.1243.
3
Dihydroisocoumarin from Xyris pterygoblephara active against dermatophyte fungi.
Phytochemistry. 2008 Jan;69(2):439-44. doi: 10.1016/j.phytochem.2007.08.002. Epub 2007 Sep 17.
4
Reducing the risk of distant metastases in breast cancer patients: role of aromatase inhibitors.
Cancer Treat Rev. 2007 Dec;33(8):681-7. doi: 10.1016/j.ctrv.2007.07.014. Epub 2007 Sep 11.
5
Developing a high-throughput system for the screening of cytochrome P450 1A1--inhibitory polyphenols.
Toxicol In Vitro. 2007 Sep;21(6):996-1002. doi: 10.1016/j.tiv.2007.04.005. Epub 2007 Apr 27.
6
Synthesis and biological evaluation of (+/-)-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer.
J Med Chem. 2007 Jun 14;50(12):2799-806. doi: 10.1021/jm070109i. Epub 2007 May 19.
7
(Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture.
Toxicol Appl Pharmacol. 2007 Jun 15;221(3):372-83. doi: 10.1016/j.taap.2007.03.016. Epub 2007 Mar 27.
8
Three-dimensional model of the human aromatase enzyme and density functional parameterization of the iron-containing protoporphyrin IX for a molecular dynamics study of heme-cysteinato cytochromes.
Proteins. 2006 Mar 1;62(4):1074-87. doi: 10.1002/prot.20829.
9
Synthesis of Abyssinone II and related compounds as potential chemopreventive agents.
Eur J Med Chem. 2006 Feb;41(2):263-7. doi: 10.1016/j.ejmech.2005.09.008. Epub 2005 Dec 2.
10
Inhibition of human cytochrome CYP 1 enzymes by flavonoids of St. John's wort.
Toxicology. 2006 Jan 16;217(2-3):194-205. doi: 10.1016/j.tox.2005.09.010. Epub 2005 Nov 4.
Zotero 插件